Skip to content

Bristol-Myers Squibb BMY FX Effect on Cash

FX Effect on Cash at other companies

Pfizer logo
PfizerPFE
$19M+371%
Johnson & Johnson logo
Johnson & JohnsonJNJ
-$25M-136%
Merck & Co. logo
Merck & Co.MRK
-$19M-112%
Incyte logo
IncyteINCY
-$2.69M-387%
Gilead Sciences logo
Gilead SciencesGILD
-$11M-158%
Cytokinetics logo
CytokineticsCYTK
-$483K-78.9%

Other financials

Income statement

See full
Revenue$11.5B+2.6%
Gross profit$8.1B-1.2%
Net income$2.7B+9.0%
EPS (diluted)$1.31+9.2%

Balance sheet

See full
Cash & equivalents$9.6B-12.0%
Total debt$44.7B-10.5%
Total equity$20.1B+15.4%
Total assets$86.5B-6.4%

Cash flow

See full
Operating cash flow$1.1B-43.5%
CapEx$347.0M+33.5%
Free cash flow$757.0M-55.3%

Valuation

See full
Market cap$117.66B+25.0%
Enterprise value$152.75B+16.8%
P/E16.2×-2.7×
P/S2.4×+0.5×

Profitability

See full
Gross margin70.5%0.0pp
Net margin15%+3.8pp
FCF margin24.6%-2.9pp

Returns & leverage

See full
Return on equity38.8%+7.3pp
Debt / equity2.2×-0.6×
Current ratio1.4×+0.1×

Where this comes from

Reported directly by Bristol-Myers Squibb in its filing.

Tagged under the XBRL concept us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents.

The official record: Bristol-Myers Squibb’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Bristol-Myers Squibb's fx effect on cash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Bristol-Myers Squibb's FX effect on cash?
Bristol-Myers Squibb (BMY) reported FX effect on cash of -$48M in Q1 2026.
How has Bristol-Myers Squibb's FX effect on cash changed year-over-year?
Bristol-Myers Squibb's FX effect on cash decreased by 172.7% year-over-year, from $66M to -$48M.
What does FX effect on cash mean?
The impact of exchange rate changes on the value of cash and equivalents held in foreign currencies.